secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001437749-24-004172
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech shareholders approve issuance of up to 14.1M shares upon warrant exercise
--------------------------------------------------------------------------------

- Proposal 1 (issuing up to 14,089,672 shares upon warrant exercise) passed: 5,627,617 for, 2,945,357 against, 4,784,514 abstain.
- Proposal 2 (adjournment if needed) passed: 10,413,712 for, 2,866,539 against, 77,237 abstain.
- Quorum of 39.97% (13,357,488 shares) achieved at Special Meeting on February 14, 2024.
- Warrants were issued in a private placement that closed on December 26, 2023; shareholder vote was required under Nasdaq Listing Rules 5635(d).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774924004172/0001437749-24-004172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774924004172/mbrx20240214_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-004172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer